Market Research Future (MRFR) anticipates strong growth for the needle free injection devices market 2020 as it is set to touch USD 25,057.4 million by 2023. The market could advance at a significant rate over the evaluation period (between 2018 and 2023)
Based on type, it is segmented into tumor cancer diagnostics, imaging procedure, endoscopy based, biopsy based and others. Of these, the imaging procedure will have the largest market share over the assessment period.
The global market of Home Healthcare is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR du...
According to a detailed report by Market Research Future (MRFR), the global ADME toxicology testing market is anticipated to register a substantial market valuation at 11.4% CAGR over the forecast period.
Factors such as the increasing prevalence of chronic diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic and treatment technologies boost the market.
Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous...
The growing cases of sports injuries, the growth of medical associations, and ongoing technological progress are expected to drive the global demand for sports medicine. Baseball and football, for example, are likely to have the highest injury rates.